Abstract
Endoscopic palliation in pancreatic cancer patients is an evolving topic due to the rising incidence and longer survival rates of patients diagnosed in a metastasized stadium. The expansive growth of malignant tumors of the pancreas causes secondary problems that often can be addressed via endoscopic procedures. The diagnostic value of ERCP imaging has been decreasing quickly, while interventional possibilities and procedures are evolving quickly. With increasing interventional possibilities, the right choice of intervention method, timing and sequence become more important to ensure maximal benefit with the least amount of interventional sessions and costs. In this article, palliative endoscopic interventions are discussed addressing biliary, pancreatic and luminal obstruction as well as EUS guided placement of therapeutic agents and their sequence and timing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Change history
26 September 2021
Chapter 79 was inadvertently published with the following
References
Ducreux M, Seufferlein T, Van Laethem JL, Laurent-Puig P, Smolenschi C, Malka D, et al. Systemic treatment of pancreatic cancer revisited. Semin Oncol. 2019;46(1):28–38.
Yachimski PS, Ross A. The future of endoscopic retrograde cholangiopancreatography. Gastroenterology. 2017;153(2):338–44.
Dumonceau JM, Tringali A, Papanikolaou IS, Blero D, Mangiavillano B, Schmidt A, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline – updated October 2017. Endoscopy. 2018;50(9):910–30.
Glomsaker T, Hoff G, Kvaloy JT, Soreide K, Aabakken L, Soreide JA. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg. 2013;100(3):373–80.
Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70(1):80–8.
Eloubeidi MA, Decker GA, Chandrasekhara V, Chathadi KV, Early DS, Evans JA, et al. The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. Gastrointest Endosc. 2016;83(1):17–28.
Daroczi T, Bor R, Fabian A, Szabo E, Farkas K, Balint A, et al. Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction. Orv Hetil. 2016;157(7):268–74.
Martinez JM, Anene A, Bentley TG, Cangelosi MJ, Meckley LM, Ortendahl JD, et al. Cost effectiveness of metal stents in relieving obstructive jaundice in patients with pancreatic cancer. J Gastrointest Cancer. 2017;48(1):58–65.
Springfeld C, Jager D, Buchler MW, Strobel O, Hackert T, Palmer DH, et al. Chemotherapy for pancreatic cancer. Presse Med. 2019;48(3 Pt 2):e159–74.
Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57(2):178–82.
Wang AY. Is plastic stenting for pancreatic cancer still relevant or obsolete in 2015? Gastrointest Endosc. 2015;81(2):367–9.
Yoon WJ, Lee JK, Lee KH, Lee WJ, Ryu JK, Kim YT, et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc. 2006;63(7):996–1000.
Li J, Li T, Sun P, Yu Q, Wang K, Chang W, et al. Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: a meta-analysis. PLoS One. 2016;11(2):e0149066.
Yang MJ, Kim JH, Yoo BM, Hwang JC, Yoo JH, Lee KS, et al. Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: a randomized controlled trial. Scand J Gastroenterol. 2015;50(12):1490–9.
Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(1):27–37.
Sogabe Y, Kodama Y, Honjo H, Aoyama I, Muramoto Y, Koga E, et al. Tumor invasion to the arteries feeding the gallbladder as a novel risk factor for cholecystitis after metallic stent placement in distal malignant biliary obstruction. Dig Endosc. 2018;30(3):380–7.
Shimizu S, Naitoh I, Nakazawa T, Hayashi K, Miyabe K, Kondo H, et al. Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction. J Gastroenterol Hepatol. 2013;28(1):68–72.
Wolfson D, Barkin JS, Chari ST, Clain JE, Bell RH Jr, Alexakis N, et al. Management of pancreatic masses. Pancreas. 2005;31(3):203–17.
Tan DM, Lillemoe KD, Fogel EL. A new technique for endoscopic removal of uncovered biliary self-expandable metal stents: stent-in-stent technique with a fully covered biliary stent. Gastrointest Endosc. 2012;75(4):923–5.
Bernon M, Kloppers C, Lindemann J, Krige JEJ, Jonas E. Recalcitrant embedded biliary self-expanding metal stents: a novel technique for endoscopic extraction. VideoGIE. 2019;4(2):72–5.
Vienne A, Hobeika E, Gouya H, Lapidus N, Fritsch J, Choury AD, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72(4):728–35.
Bulajic M, Panic N, Radunovic M, Scepanovic R, Perunovic R, Stevanovic P, et al. Clinical outcome in patients with hilar malignant strictures type II Bismuth-Corlette treated by minimally invasive unilateral versus bilateral endoscopic biliary drainage. Hepatobiliary Pancreat Dis Int. 2012;11(2):209–14.
Moole H, Dharmapuri S, Duvvuri A, Dharmapuri S, Boddireddy R, Moole V, et al. Endoscopic versus percutaneous biliary drainage in palliation of advanced malignant hilar obstruction: a meta-analysis and systematic review. Can J Gastroenterol Hepatol. 2016;2016:4726078.
Choi JH, Lee SH, You MS, Shin BS, Choi YH, Kang J, et al. Step-wise endoscopic approach to palliative bilateral biliary drainage for unresectable advanced malignant hilar obstruction. Sci Rep. 2019;9(1):13207.
Ge PS, Hamerski CM, Watson RR, Komanduri S, Cinnor BB, Bidari K, et al. Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy. Gastrointest Endosc. 2015;81(2):360–6.
Rathmayer M, Heinlein W, Reiss C, Albert JG, Akoglu B, Braun M, et al. Cost assessment for endoscopic procedures in the German diagnosis-related-group (DRG) system – 5 year cost data analysis of the German Society of Gastroenterology project. Z Gastroenterol. 2017;55(10):1038–51.
Walter D, van Boeckel PG, Groenen MJ, Weusten BL, Witteman BJ, Tan G, et al. Cost efficacy of metal stents for palliation of extrahepatic bile duct obstruction in a randomized controlled trial. Gastroenterology. 2015;149(1):130–8.
Lamarca A, Rigby C, McNamara MG, Hubner RA, Valle JW. Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy. World J Gastroenterol. 2016;22(26):6065–75.
Wadsworth CA, Westaby D, Khan SA. Endoscopic radiofrequency ablation for cholangiocarcinoma. Curr Opin Gastroenterol. 2013;29(3):305–11.
Wang K, Zhu J, Xing L, Wang Y, Jin Z, Li Z. Assessment of efficacy and safety of EUS-guided biliary drainage: a systematic review. Gastrointest Endosc. 2016;83(6):1218–27.
Oh D, Park DH, Song TJ, Lee SS, Seo DW, Lee SK, et al. Optimal biliary access point and learning curve for endoscopic ultrasound-guided hepaticogastrostomy with transmural stenting. Ther Adv Gastroenterol. 2017;10(1):42–53.
Poincloux L, Rouquette O, Buc E, Privat J, Pezet D, Dapoigny M, et al. Endoscopic ultrasound-guided biliary drainage after failed ERCP: cumulative experience of 101 procedures at a single center. Endoscopy. 2015;47(9):794–801.
Bishay K, Boyne D, Yaghoobi M, Khashab MA, Shorr R, Ichkhanian Y, et al. Endoscopic ultrasound-guided transmural approach versus ERCP-guided transpapillary approach for primary decompression of malignant biliary obstruction: a meta-analysis. Endoscopy. 2019;51(10):950–60.
Ardengh JC, Lopes CV, Kemp R, Dos Santos JS. Different options of endosonography-guided biliary drainage after endoscopic retrograde cholangio-pancreatography failure. World J Gastrointest Endosc. 2018;10(5):99–108.
Uemura S, Iwashita T, Iwata K, Mukai T, Osada S, Sekino T, et al. Endoscopic duodenal stent versus surgical gastrojejunostomy for gastric outlet obstruction in patients with advanced pancreatic cancer. Pancreatology. 2018; https://doi.org/10.1016/j.pan.2018.04.015.
Stier MW, Waxman I. Lumen-apposing metal stents: which one and why? Gastrointest Endosc Clin N Am. 2018;28(2):207–17.
Ogura T, Higuchi K. Technical tips for endoscopic ultrasound-guided hepaticogastrostomy. World J Gastroenterol. 2016;22(15):3945–51.
Shah SL, Perez-Miranda M, Kahaleh M, Tyberg A. Updates in therapeutic endoscopic ultrasonography. J Clin Gastroenterol. 2018;52(9):765–72.
Cho DH, Lee SS, Oh D, Song TJ, Park DH, Seo DW, et al. Long-term outcomes of a newly developed hybrid metal stent for EUS-guided biliary drainage (with videos). Gastrointest Endosc. 2017;85(5):1067–75.
De Cassan C, Bories E, Pesenti C, Caillol F, Godat S, Ratone JP, et al. Use of partially covered and uncovered metallic prosthesis for endoscopic ultrasound-guided hepaticogastrostomy: results of a retrospective monocentric study. Endosc Ultrasound. 2017;6(5):329–35.
Park JK, Woo YS, Noh DH, Yang JI, Bae SY, Yun HS, et al. Efficacy of EUS-guided and ERCP-guided biliary drainage for malignant biliary obstruction: prospective randomized controlled study. Gastrointest Endosc. 2018;88(2):277–82.
Costamagna G, Gabbrielli A, Mutignani M, Perri V, Crucitti F. Treatment of “obstructive” pain by endoscopic drainage in patients with pancreatic head carcinoma. Gastrointest Endosc. 1993;39(6):774–7.
Tham TC, Lichtenstein DR, Vandervoort J, Wong RC, Slivka A, Banks PA, et al. Pancreatic duct stents for “obstructive type” pain in pancreatic malignancy. Am J Gastroenterol. 2000;95(4):956–60.
Costamagna G, Mutignani M. Pancreatic stenting for malignant ductal obstruction. Dig Liver Dis. 2004;36(9):635–8.
Wehrmann T, Riphaus A, Frenz MB, Martchenko K, Stergiou N. Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain. Eur J Gastroenterol Hepatol. 2005;17(12):1395–400.
Fasanella KE, Davis B, Lyons J, Chen Z, Lee KK, Slivka A, et al. Pain in chronic pancreatitis and pancreatic cancer. Gastroenterol Clin N Am. 2007;36(2):335–64. ix
Ceyhan GO, Demir IE, Rauch U, Bergmann F, Muller MW, Buchler MW, et al. Pancreatic neuropathy results in “neural remodeling” and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer. Am J Gastroenterol. 2009;104(10):2555–65.
Dawod E, Kahaleh M. Management of benign and malignant pancreatic duct strictures. Clin Endosc. 2018;51(2):156–60.
Kamata K, Takenaka M, Minaga K, Sakurai T, Watanabe T, Nishida N, et al. EUS-guided pancreatic duct drainage for repeat pancreatitis in a patient with pancreatic cancer. Oncology. 2017;93(Suppl 1):87–8.
Singh SM, Longmire WP Jr, Reber HA. Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg. 1990;212(2):132–9.
Tsauo J, Yoo MW, Song HY, Hwang DW, Park JH, Ryu MH, et al. Partially-covered stent placement versus surgical gastrojejunostomy for the palliation of malignant gastroduodenal obstruction secondary to pancreatic cancer. Abdom Radiol (NY). 2016;41(11):2233–40.
Yoshida Y, Fukutomi A, Tanaka M, Sugiura T, Kawata N, Kawai S, et al. Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer. Pancreatology. 2017;17(6):983–9.
Yamao K, Kitano M, Takenaka M, Minaga K, Sakurai T, Watanabe T, et al. Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan. Gastrointest Endosc. 2018;88(1):66–75.
Staub J, Siddiqui A, Taylor LJ, Loren D, Kowalski T, Adler DG. ERCP performed through previously placed duodenal stents: a multicenter retrospective study of outcomes and adverse events. Gastrointest Endosc. 2018;87(6):1499–504.
Rimbas M, Larghi A, Costamagna G. Endoscopic ultrasound-guided gastroenterostomy: are we ready for prime time? Endosc Ultrasound. 2017;6(4):235–40.
Itoi T, Baron TH, Khashab MA, Tsuchiya T, Irani S, Dhir V, et al. Technical review of endoscopic ultrasonography-guided gastroenterostomy in 2017. Dig Endosc. 2017;29(4):495–502.
Perez-Miranda M, Tyberg A, Poletto D, Toscano E, Gaidhane M, Desai AP, et al. EUS-guided gastrojejunostomy versus laparoscopic gastrojejunostomy: an international collaborative study. J Clin Gastroenterol. 2017;51(10):896–9.
Khashab MA, Bukhari M, Baron TH, Nieto J, El Zein M, Chen YI, et al. International multicenter comparative trial of endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for the treatment of malignant gastric outlet obstruction. Endosc Int Open. 2017;5(4):E275–81.
Krafft MR, Hsueh W, James TW, Runge TM, Baron TH, Khashab MA, et al. The EDGI new take on EDGE: EUS-directed transgastric intervention (EDGI), other than ERCP, for Roux-en-Y gastric bypass anatomy: a multicenter study. Endosc Int Open. 2019;7(10):E1231–40.
Kedia P, Tyberg A, Kumta NA, Gaidhane M, Karia K, Sharaiha RZ, et al. EUS-directed transgastric ERCP for Roux-en-Y gastric bypass anatomy: a minimally invasive approach. Gastrointest Endosc. 2015;82(3):560–5.
Wang BC, Furnback W. Modelling the long-term outcomes of bariatric surgery: a review of cost-effectiveness studies. Best Pract Res Clin Gastroenterol. 2013;27(6):987–95.
Kedia P, Tarnasky PR, Nieto J, Steele SL, Siddiqui A, Xu MM, et al. EUS-directed transgastric ERCP (EDGE) versus laparoscopy-assisted ERCP (LA-ERCP) for Roux-en-Y gastric bypass (RYGB) anatomy: a multicenter early comparative experience of clinical outcomes. J Clin Gastroenterol. 2019;53(4):304–8.
Irani S, Yang J, Khashab MA. Mitigating lumen-apposing metal stent dislodgment and allowing safe, single-stage EUS-directed transgastric ERCP. VideoGIE. 2018;3(10):322–4.
Yasuda I, Wang HP. Endoscopic ultrasound-guided celiac plexus block and neurolysis. Dig Endosc. 2017;29(4):455–62.
Michaels AJ, Draganov PV. Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis. World J Gastroenterol. 2007;13(26):3575–80.
Bang JY, Sutton B, Hawes RH, Varadarajulu S. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos). Gastrointest Endosc. 2019;89(1):58–66.
Han J, Chang KJ. Endoscopic ultrasound-guided direct intervention for solid pancreatic tumors. Clin Endosc. 2017;50(2):126–37.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Waldthaler, A., Rutkowski, W., Löhr, JM. (2021). Palliative Endoscopic Therapy in Pancreatic Cancer. In: Søreide, K., Stättner, S. (eds) Textbook of Pancreatic Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-53786-9_79
Download citation
DOI: https://doi.org/10.1007/978-3-030-53786-9_79
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53785-2
Online ISBN: 978-3-030-53786-9
eBook Packages: MedicineMedicine (R0)